XML 31 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Impact of Recently Issued Accounting Standards (Tables)
6 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Schedule of New Accounting Pronouncements and Changes in Accounting Principles
The cumulative effect of the changes made to the Company's condensed consolidated balance sheet as of January 1, 2018 for the adoption of ASU No. 2016-01 are included in the table below:
Equity:
Balance at December 31, 2017
 
Adjustments due to ASU No. 2016-01
 
Balance at January 1, 2018
Accumulated deficit
$
(523,356,317
)
 
$
231,366

 
$
(523,124,951
)
Accumulated other comprehensive loss
$
(117,005
)
 
$
(231,366
)
 
$
(348,371
)
The following table illustrates the impact that adopting Topic 606 has had on the Company's reported results in the condensed consolidated statement of operations for the three months ended June 30, 2018.
 
Balances Without Adoption of Topic 606 for the Three Months Ended June 30, 2018
 
Impact of Adopting Topic 606
 
As Reported for the Three Months Ended June 30, 2018
Revenues:
 
 
 
 
 
Revenue under collaborative research and development arrangements
$
24,385,852


$

 
$
24,385,852

Revenue under collaborative research and development arrangements with affiliated entities
60,319



 
60,319

Grants and miscellaneous revenue
1,459,684


(1,457,094
)
 
2,590

Grants and miscellaneous revenue from affiliated entity
454,820


(454,820
)
 

Total revenues
26,360,675

 
(1,911,914
)
 
24,448,761

Operating expenses:
 
 
 
 
 
Research and development
24,374,534

 
(1,911,914
)
 
22,462,620

General and administrative
7,189,310

 

 
7,189,310

Total operating expenses
$
31,563,844

 
$
(1,911,914
)
 
$
29,651,930


The following table illustrates the impact that adopting Topic 606 has had on the Company's reported results in the condensed consolidated statement of operations for the six months ended June 30, 2018.
 
Balances Without Adoption of Topic 606 for the Six Months Ended June 30, 2018
 
Impact of Adopting Topic 606
 
As Reported for the Six Months Ended June 30, 2018
Revenues:
 
 
 
 
 
Revenue under collaborative research and development arrangements
$
25,674,898

 
$

 
$
25,674,898

Revenue under collaborative research and development arrangements with affiliated entities
208,327

 

 
208,327

Grants and miscellaneous revenue
2,016,674

 
(1,921,494
)
 
95,180

Grants and miscellaneous revenue from affiliated entity
2,212,571

 
(2,212,571
)
 

Total revenues
30,112,470

 
(4,134,065
)
 
25,978,405

Operating expenses:
 
 
 
 
 
Research and development
51,174,436

 
(4,134,065
)
 
47,040,371

General and administrative
16,887,325

 

 
16,887,325

Total operating expenses
$
68,061,761

 
$
(4,134,065
)
 
$
63,927,696